---
figid: PMC7738893__thnov11p1493g001
figlink: pmc/articles/PMC7738893/figure/F1/
number: Figure 1
caption: Mechanisms of action of monoclonal antibodies (mAb) in cancer therapy. Antibody-based
  therapeutic strategies (A-E) in solid tumors include both direct and indirect tumor
  cell killing. A) Antibodies acting by functional neutralization of receptor(s) on
  tumor cells. Antibody binding to overexpressed HER family receptors (HER1, HER2,
  HER3) on tumor cells, interfere with ligand binding or inhibit their homo- and hetero-
  dimerization with other HER family members and inhibit activation of downstream
  MAPK/ERK and PI3K/AKT signaling pathways that promote growth, migration, and proliferation
  of tumor cells. Antibodies against c- met receptor block STAT3/JNK and PI3K/AKT
  signaling and inhibit tumor cell transformation, survival, and proliferation. Recently
  developed class of agonistic antibodies to TNF superfamily death receptors DR4 and
  DR5 stimulate apoptosis through Bax/Bak and Caspase 9 pathway. B) Binding of antibodies
  to tumor vasculature receptors VEGFR1, VEGFR2, or their ligand VEGFA inhibits endothelial
  cell proliferation, migration, vascular permeability, and angiogenesis by interfering
  with PI3K/AKT, MAPK, and MEK/ERK signaling. C) Antibodies to immune checkpoint molecules,
  which include inhibitory (CTLA4) and co-inhibitory receptors (PD-1) present on immune
  cells or their ligands upregulated by tumor cells (PD-L1), reverse T cell exhaustion.
  Anti-PD-1 antibodies interfere with tyrosine phosphatase SHP2 recruitment and allow
  TCR (CD3) induced PI3K/AKT and MAPK signaling activation, cell survival, and proliferation.
  Anti-CTLA4 antibodies inhibit PP2A recruitment and CD3 dephosphorylation and activate
  PI3K/AKT, mTOR, NF-kB signaling pathways. D) Antibodies bound to tumor cells display
  antibody-dependent cell cytotoxic (ADCC) activity by engaging FcγR, present on the
  effector cells such as NK cells, neutrophils, and macrophages. This interaction
  induces ITAM phosphorylation and binding to tyrosine kinases ZAP-70 and SYK, which
  in turn activate PI3K and SOS. PIP3 generated through PI3K activation recruit BTK
  and PLCγ. RAS, BTK, and PLC activate downstream ERK, p38 and JNK signaling pathway
  along with calcium release from the endoplasmic reticulum (ER), which result in
  the release of cytokines and cytotoxic granules as IFNγ, perforin, and granzymes
  from NK cells and actin remodeling, which finally cause tumor cell apoptosis. Antibody
  bound tumor cells are recognized by neutrophils and macrophages and trigger oxidative
  burst and phagocytosis by neutrophils and macrophages, leading to lysosomal degradation
  of tumor cells. E) Antibody-drug conjugates (ADCs) possess specificity of mAb and
  cytotoxic potential of payload drug. ADCs bind to target antigen, get internalized,
  and undergo endocytic processing. Once in the cell, ADCs cleavage occurs, and the
  active cytotoxic drug is released into the cytoplasm where it inhibits microtubule
  polymerization and subsequently, tumor cell death. HER, human epidermal growth factor
  receptor; MAPK, mitogen- activated protein kinase; ERK, extracellular signal- regulated
  kinase; MEK, MAPK/Erk kinase 1/2; PI3K, phosphoinositide 3-kinase; SOS, son of sevenless
  homologue; STAT3, signal transducer and activator of transcription 3; JNK, c-JUN
  N- terminal kinase; DR4, death receptor 4; DR5, death receptor 5; Bax, Bcl-2-associated
  X protein; VEGFR1, vascular endothelial growth factor receptor-1; VEGFR2, vascular
  endothelial growth factor receptor-2; VEGFA, vascular endothelial growth factor
  A; FcγR; Fc gamma receptor; PIP3, phosphatidylinositol-3,4,5-trisphosphate; NK,
  natural killer; ITAM, immunoreceptor tyrosine- based activation motif; SYK, spleen
  tyrosine kinase; BTK, bruton's tyrosine kinase; PLCγ, phospholipase C gamma; RAS,
  rat sarcoma viral oncogene homolog; CTLA-4, cytotoxic T lymphocyte antigen 4; PD-1,
  program death-1; PD-L1, program death-1 ligand; SHP2, src homology phosphatase 2;
  TCR, t cell receptor; CD3, cluster of differentiation 3; mTOR, mammalian target
  of rapamycin; NF-kB, nuclear factor kappa-light-chain-enhancer of activated B cells.
pmcid: PMC7738893
papertitle: The Current Landscape of Antibody-based Therapies in Solid Malignancies.
reftext: Ashu Shah, et al. Theranostics. 2021;11(3):1493-1512.
pmc_ranked_result_index: '123959'
pathway_score: 0.9384199
filename: thnov11p1493g001.jpg
figtitle: Action of monoclonal antibodies (mAb) in cancer therapy
year: '2021'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7738893__thnov11p1493g001.html
  '@type': Dataset
  description: Mechanisms of action of monoclonal antibodies (mAb) in cancer therapy.
    Antibody-based therapeutic strategies (A-E) in solid tumors include both direct
    and indirect tumor cell killing. A) Antibodies acting by functional neutralization
    of receptor(s) on tumor cells. Antibody binding to overexpressed HER family receptors
    (HER1, HER2, HER3) on tumor cells, interfere with ligand binding or inhibit their
    homo- and hetero- dimerization with other HER family members and inhibit activation
    of downstream MAPK/ERK and PI3K/AKT signaling pathways that promote growth, migration,
    and proliferation of tumor cells. Antibodies against c- met receptor block STAT3/JNK
    and PI3K/AKT signaling and inhibit tumor cell transformation, survival, and proliferation.
    Recently developed class of agonistic antibodies to TNF superfamily death receptors
    DR4 and DR5 stimulate apoptosis through Bax/Bak and Caspase 9 pathway. B) Binding
    of antibodies to tumor vasculature receptors VEGFR1, VEGFR2, or their ligand VEGFA
    inhibits endothelial cell proliferation, migration, vascular permeability, and
    angiogenesis by interfering with PI3K/AKT, MAPK, and MEK/ERK signaling. C) Antibodies
    to immune checkpoint molecules, which include inhibitory (CTLA4) and co-inhibitory
    receptors (PD-1) present on immune cells or their ligands upregulated by tumor
    cells (PD-L1), reverse T cell exhaustion. Anti-PD-1 antibodies interfere with
    tyrosine phosphatase SHP2 recruitment and allow TCR (CD3) induced PI3K/AKT and
    MAPK signaling activation, cell survival, and proliferation. Anti-CTLA4 antibodies
    inhibit PP2A recruitment and CD3 dephosphorylation and activate PI3K/AKT, mTOR,
    NF-kB signaling pathways. D) Antibodies bound to tumor cells display antibody-dependent
    cell cytotoxic (ADCC) activity by engaging FcγR, present on the effector cells
    such as NK cells, neutrophils, and macrophages. This interaction induces ITAM
    phosphorylation and binding to tyrosine kinases ZAP-70 and SYK, which in turn
    activate PI3K and SOS. PIP3 generated through PI3K activation recruit BTK and
    PLCγ. RAS, BTK, and PLC activate downstream ERK, p38 and JNK signaling pathway
    along with calcium release from the endoplasmic reticulum (ER), which result in
    the release of cytokines and cytotoxic granules as IFNγ, perforin, and granzymes
    from NK cells and actin remodeling, which finally cause tumor cell apoptosis.
    Antibody bound tumor cells are recognized by neutrophils and macrophages and trigger
    oxidative burst and phagocytosis by neutrophils and macrophages, leading to lysosomal
    degradation of tumor cells. E) Antibody-drug conjugates (ADCs) possess specificity
    of mAb and cytotoxic potential of payload drug. ADCs bind to target antigen, get
    internalized, and undergo endocytic processing. Once in the cell, ADCs cleavage
    occurs, and the active cytotoxic drug is released into the cytoplasm where it
    inhibits microtubule polymerization and subsequently, tumor cell death. HER, human
    epidermal growth factor receptor; MAPK, mitogen- activated protein kinase; ERK,
    extracellular signal- regulated kinase; MEK, MAPK/Erk kinase 1/2; PI3K, phosphoinositide
    3-kinase; SOS, son of sevenless homologue; STAT3, signal transducer and activator
    of transcription 3; JNK, c-JUN N- terminal kinase; DR4, death receptor 4; DR5,
    death receptor 5; Bax, Bcl-2-associated X protein; VEGFR1, vascular endothelial
    growth factor receptor-1; VEGFR2, vascular endothelial growth factor receptor-2;
    VEGFA, vascular endothelial growth factor A; FcγR; Fc gamma receptor; PIP3, phosphatidylinositol-3,4,5-trisphosphate;
    NK, natural killer; ITAM, immunoreceptor tyrosine- based activation motif; SYK,
    spleen tyrosine kinase; BTK, bruton's tyrosine kinase; PLCγ, phospholipase C gamma;
    RAS, rat sarcoma viral oncogene homolog; CTLA-4, cytotoxic T lymphocyte antigen
    4; PD-1, program death-1; PD-L1, program death-1 ligand; SHP2, src homology phosphatase
    2; TCR, t cell receptor; CD3, cluster of differentiation 3; mTOR, mammalian target
    of rapamycin; NF-kB, nuclear factor kappa-light-chain-enhancer of activated B
    cells.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TNFRSF10B
  - TNFRSF10A
  - SLTM
  - VEGFA
  - ERBB2
  - CD274
  - PDCD1LG2
  - ERBB3
  - PDCD1
  - TRA
  - TRB
  - TRD
  - TRG
  - APC
  - CDC42
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - PLCG1
  - PLCG2
  - FADD
  - CD86
  - PTPN11
  - ZAP70
  - SRC
  - PRKCA
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCQ
  - PRKCB
  - PRKCD
  - PRKCI
  - PRKCZ
  - PRKD3
  - CASP1
  - CASP2
  - CASP8
  - CASP9
  - CASP14
  - CASP12
  - CASP3
  - CASP4
  - CASP5
  - CASP6
  - CASP7
  - CASP10
  - CTLA4
  - HRAS
  - KRAS
  - NRAS
  - ARAF
  - BRAF
  - RAF1
  - CD3E
  - CD3D
  - CD3G
  - CD247
  - STAT3
  - BAX
  - BAK1
  - MAP2K1
  - MAP2K2
  - AKT2
  - AKT3
  - AKT1
  - MAPK8
  - MAPK9
  - MAPK10
  - MAPK3
  - MAPK1
  - MTOR
  - NFATC1
  - NFATC2
  - NFATC3
  - NFATC4
  - NFAT5
  - NFKB1
  - NFKB2
  - REL
  - RELA
  - RELB
  - IL2
  - SYK
  - SOS1
  - SOS2
  - MAPK14
  - MAPK11
  - MAPK13
  - MAPK12
  - TCR
  - Calcium
  - Cytotoxicity
genes:
- word: DR4/5
  symbol: DR5
  source: hgnc_alias_symbol
  hgnc_symbol: TNFRSF10B
  entrez: '8795'
- word: DR4/5
  symbol: DR4
  source: hgnc_alias_symbol
  hgnc_symbol: TNFRSF10A
  entrez: '8797'
- word: C-Met
  symbol: Met
  source: hgnc_alias_symbol
  hgnc_symbol: SLTM
  entrez: '79811'
- word: VEGFA
  symbol: VEGFA
  source: hgnc_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: Her2
  symbol: HER2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: PD-L1/L2
  symbol: PD-L1
  source: hgnc_alias_symbol
  hgnc_symbol: CD274
  entrez: '29126'
- word: PD-L1/L2
  symbol: PD-L2
  source: hgnc_alias_symbol
  hgnc_symbol: PDCD1LG2
  entrez: '80380'
- word: Her3
  symbol: HER3
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB3
  entrez: '2065'
- word: Her2
  symbol: HER2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: PD-1
  symbol: PD-1
  source: hgnc_alias_symbol
  hgnc_symbol: PDCD1
  entrez: '5133'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRA
  entrez: '6955'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRB
  entrez: '6957'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRD
  entrez: '6964'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRG
  entrez: '6965'
- word: АРС
  symbol: APC
  source: hgnc_symbol
  hgnc_symbol: APC
  entrez: '324'
- word: CDC42
  symbol: CDC42
  source: hgnc_symbol
  hgnc_symbol: CDC42
  entrez: '998'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PLCY
  symbol: PLCG
  source: bioentities_symbol
  hgnc_symbol: PLCG1
  entrez: '5335'
- word: PLCY
  symbol: PLCG
  source: bioentities_symbol
  hgnc_symbol: PLCG2
  entrez: '5336'
- word: FADD
  symbol: FADD
  source: hgnc_symbol
  hgnc_symbol: FADD
  entrez: '8772'
- word: CD86
  symbol: CD86
  source: hgnc_symbol
  hgnc_symbol: CD86
  entrez: '942'
- word: SHP2
  symbol: SHP2
  source: hgnc_alias_symbol
  hgnc_symbol: PTPN11
  entrez: '5781'
- word: ZAP70
  symbol: ZAP70
  source: hgnc_symbol
  hgnc_symbol: ZAP70
  entrez: '7535'
- word: Src
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP1
  entrez: '834'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP2
  entrez: '835'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP9
  entrez: '842'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP14
  entrez: '23581'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP12
  entrez: '100506742'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP4
  entrez: '837'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP5
  entrez: '838'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP6
  entrez: '839'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP7
  entrez: '840'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP10
  entrez: '843'
- word: CTLA4
  symbol: CTLA4
  source: hgnc_symbol
  hgnc_symbol: CTLA4
  entrez: '1493'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: CD3
  symbol: CD3
  source: bioentities_symbol
  hgnc_symbol: CD3E
  entrez: '916'
- word: CD3
  symbol: CD3
  source: bioentities_symbol
  hgnc_symbol: CD3D
  entrez: '915'
- word: CD3
  symbol: CD3
  source: bioentities_symbol
  hgnc_symbol: CD3G
  entrez: '917'
- word: CD3
  symbol: CD3
  source: bioentities_symbol
  hgnc_symbol: CD247
  entrez: '919'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: Bax/BAK
  symbol: BAX
  source: hgnc_symbol
  hgnc_symbol: BAX
  entrez: '581'
- word: Bax/BAK
  symbol: BAK
  source: hgnc_alias_symbol
  hgnc_symbol: BAK1
  entrez: '578'
- word: SHP2
  symbol: SHP2
  source: hgnc_alias_symbol
  hgnc_symbol: PTPN11
  entrez: '5781'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP1
  entrez: '834'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP2
  entrez: '835'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP9
  entrez: '842'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP14
  entrez: '23581'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP12
  entrez: '100506742'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP4
  entrez: '837'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP5
  entrez: '838'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP6
  entrez: '839'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP7
  entrez: '840'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP10
  entrez: '843'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: NFAT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC1
  entrez: '4772'
- word: NFAT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC2
  entrez: '4773'
- word: NFAT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC3
  entrez: '4775'
- word: NFAT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC4
  entrez: '4776'
- word: NFAT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFAT5
  entrez: '10725'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: IL-2
  symbol: IL-2
  source: hgnc_alias_symbol
  hgnc_symbol: IL2
  entrez: '3558'
- word: Her2
  symbol: HER2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: SYK
  symbol: SYK
  source: hgnc_symbol
  hgnc_symbol: SYK
  entrez: '6850'
- word: ZAP70
  symbol: ZAP70
  source: hgnc_symbol
  hgnc_symbol: ZAP70
  entrez: '7535'
- word: SoS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: SoS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: ERK,p38,JNK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK,p38,JNK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ERK,p38,JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: ERK,p38,JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: ERK,p38,JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: ERK,p38,JNK
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: ERK,p38,JNK
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: ERK,p38,JNK
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: ERK,p38,JNK
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: p38,
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: p38,
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: p38,
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: p38,
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: ERK,
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK,
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
chemicals:
- word: TCR
  source: MESH
  identifier: D017260
- word: Calcium
  source: MESH
  identifier: D002118
diseases:
- word: Cytotoxicity
  source: MESH
  identifier: D064420
---
